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Hemodynamic changes associated with bypass
stenosis regression
John B. Taggert, MD, Ann Marie Kupinski, PhD, R. Clement Darling III, MD, Meghan Trub, BA, and
Philip S. K. Paty, MD, Albany, NY
Objective: Ultrasound scanning is used to detect velocity increases indicative of a bypass stenosis. Subsequent examina-
tions have shown regression of some stenotic lesions. This study examined hemodynamic changes that coincided with
stenosis regression.
Methods:Duplex ultrasound scans were used to record the peak systolic velocity (PSV) and volume flow from proximal and
distal segments of infrainguinal bypasses. Valve remnants or other image defects were also noted. The PSV ratio (Vr) was
calculated as the PSV at a stenosis divided by the PSV proximal to the lesion. A stenosis was defined as Vr >2.0.
Results: An initial ultrasound scan performed 31  6 days after surgery revealed a stenosis in 68 of 565 bypasses. In six
bypasses, the increased PSV (272  61 cm/s) and Vr (3.4  1.3) were sustained during the follow-up period of 8  3
months. In 27 bypasses with a PSV of 335  63 cm/s and a Vr of 4.0  1.6, the stenosis was repaired. In 35 bypasses
with a PSV of 261 82 cm/s and Vr of 3.2 1.2, stenosis regression occurred with no increases in PSV observed on later
scans. In this group, proximal bypass flow decreased during the follow-up interval from 247  130 mL/min to 151 
135 mL/min and distal flow from 180  102 mL/min to 103  54 mL/min (P < .05, paired t test). Ultrasound image
abnormalities were noted in 4 bypasses (67%) with persistent stenoses, 14 with repaired stenoses (52%), and 10 with
resolved stenoses (29%).
Conclusion: These data indicate early postoperative hyperemia is present in bypasses, demonstrating focal velocity
increases. Such velocity increases may be the result of the bypass conduit acting as a flow-limiting lesion until the
hyperemia subsides. As the blood flow decreases so does the PSV, giving the appearance of stenosis regression. (J Vasc
Surg 2005;41:1013-7.)Detection and correction of stenotic lesions in failing
lower extremity vein bypasses can improve long-term pa-
tency. Whittemore et al1 demonstrated 5-year patency rates
of 80% when stenotic lesions were corrected before graft
thrombosis compared with 40% when lesions were cor-
rected after thrombosis. Duplex ultrasound surveillance can
detect and grade bypass stenosis; however, duplex-derived
bypass velocity criteria for bypass revision have varied in the
literature.
Bandyk et al2 recommend intervention when the peak
systolic velocity (PSV) is 300 cm/s and the velocity ratio
(Vr) is 3.4. The Vr is defined as the PSV in the stenotic
segment divided by the systolic velocity in the nonstenotic
adjacent proximal segment. Similar recommendations for
stenosis repair when the PSV 300 cm/s and the Vr 3.5
have been made by Westerband et al.3
The velocity criteria for intervention recommended by
these two groups correspond to a 70% stenosis on an-
giography. Less severe lesions with 50% to 70% stenosis at
angiography have duplex-derived velocities with PSV
150 and 300 cm/s and Vr 1.5 and 3.4. Stenotic
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doi:10.1016/j.jvs.2005.03.010lesions that do not meet criteria for intervention may be
monitored by ultrasound surveillance to determine lesion
progression. However, many stenotic lesions that do not
meet criteria for repair undergo velocity regression during
serial surveillance. Mills et al4 have shown that 32% of
elevated ultrasound-derived bypass velocities regress dur-
ing surveillance.
In this study, we retrospectively reviewed a cohort of
patients with elevated lower extremity vein bypass velocities
discovered during surveillance. Patient demographics, by-
pass characteristics, indication, and duplex-derived veloci-
ties are described for bypasses that were either revised or
followed without revision. Additionally, we reviewed vol-
ume flow data measured during bypass surveillance for this
cohort. Our goal was to identify characteristics unique to
those bypasses in which stenotic velocities appeared to
regress.
METHODS
A retrospective review was conducted of patients with
infrainguinal autogenous vein bypass grafts who were in
active follow-up in our primary vascular laboratory. Patients
in whom a stenosis was identified on ultrasound scan and
who had either at least one subsequent ultrasound scan or
underwent a bypass revision were included in the study.
Vascular laboratory criteria define a bypass stenosis as a PSV
150 cm/s or a Vr 2.0. Demographic data, including
age, sex, smoking, diabetes mellitus, and renal failure were
obtained from a computerized vascular surgery registry for
the identified patients. Indications for surgery, type of
bypass (ie, in situ, reversed vein, or orthograde excised
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Surveillance method. The duplex ultrasound evalua-
tion was performed according to standardized laboratory
protocols. The entire bypass and the inflow and outflow
vessels were examined. The PSV and the end-diastolic
velocities were recorded from the inflow artery, proximal
anastomosis, proximal segment of the bypass graft, distal
segment of the bypass graft, distal anastomosis, and outflow
artery. The PSV and end-diastolic velocities were recorded
proximal to, within, and distal to any segment of the bypass
that appeared to display elevated velocities. The Vr was
calculated as the ratio of the PSVmeasured at a stenotic area
divided by the PSV in the segment immediately proximal to
the stenosis.
Volume flow was measured within the proximal and
distal segments of the bypass graft. The volume flow was
calculated as a product of the vessel area and the time-
average velocity. The vascular technologist manually placed
calipers on the B-mode image of the bypass graft to mea-
sure the vessel diameter, which the ultrasound system soft-
ware used to automatically calculate the vessel area. A 3- to
4-second interval was used to obtain the spectral Doppler
signal to calculate the time-average velocity.
The ultrasound system algorithms average the veloci-
ties obtained at each interval in time, which represents the
velocity spectrum across the blood vessel at that moment in
time. The software then calculates a mean of each of these
individual means over the 3 to 4 seconds selected, thus
producing a mean of the means or time-average velocity.
The 3- to 4-second interval was chosen to obtain a repre-
sentative signal over several cardiac cycles. This method for
measuring volume flow was previously validated by this
laboratory.5
The B-mode image was closely interrogated at areas of
increased velocity. Valve leaflets, remnants, or other in-
traluminal defects were noted.
The first ultrasound study was performed within 2
weeks of hospital discharge, with a second study performed
3 months postoperatively. These initial examinations were
used to stratify patients into two surveillance groups. Pa-
tients with a single segment of lower extremity vein without
any abnormalities underwent biannual duplex ultrasound
surveillance. Patients with spliced vein bypasses, arm vein
conduit, or patients considered high risk because of limited
conduit availability, poor outflow vessels, or a focal elevated
velocity not warranting immediate revision were followed
every 3 months for the first 2 years. Pulse volume record-
ings and ankle/brachial indices were performed at each visit
in addition to the duplex ultrasound scan.
Demographic data, with the exception of age, were
compared with a 2 analysis. Patient age and velocity data
for revised and nonrevised bypasses were compared with an
unpaired Student’s t test. The initial and follow-up volume
flow for bypasses that either progressed to revision or
regressed were compared by using a paired Student t test.
Data are expressed as mean  standard deviation.RESULTS
We reviewed 565 vascular laboratory charts of patients
with infrainguinal vein bypass grafts; 68 bypasses (12%)
were identified with PSV 150 cm/s and a Vr 2.0. Of
these, 27 ultimately underwent revision and 41 underwent
surveillance without revision. The demographics and ath-
erosclerosis risk factors for the revised and nonrevised
group were similar, with the exception of smoking (Table
I). Smokers represented 34% of the nonrevised group and
11% of the revised group. The indications for bypass were
similar between the groups; approximately 90% were per-
formed for a limb salvage indication (Table I).
The conduit and outflow level were similar for the two
groups. In situ bypasses comprised 48% of the revised and
56% of the nonrevised group. Spliced vein bypasses were
equally distributed, with 26% in the revised group and 24%
in the nonrevised group (Table II). The differences in
outflow level between the two groups did not reach statis-
tical significance. A distal anastomosis at the below-knee
popliteal artery was present in 18% of the revised group and
in 29% of the nonrevised group. Outflow to the tibial level
was present in 78% of the revised and in 61% of the
nonrevised bypasses (Table II).
Nineteen of the 68 bypasses were revised on the basis of
an abnormal duplex study without any prior abnormal
study, which represents 3.3% of 565 original charts re-
viewed. Seventeen of the 19 were revised as a result of the
first postoperative duplex, and two had a new focal velocity
elevation after prior normal studies.
Forty-nine bypasses underwent frequent surveillance
Table I. Demographics and indications for bypass
Demographics
Revised
(n  27) (%)
Nonrevised
(n  41) (%)
Age 72.8 72.3
Sex:
Female 11 (41) 16 (39)
Male 16 (59) 25 (61)
Diabetes mellitus 14 (52) 11 (27)
Tobacco 3 (11) 14 (34)
Indication
Claudication 3 (11) 5 (12)
Limb salvage 24 (89) 36 (88)
Table II. Conduit and outflow vessel
Conduit
Revised
(n  27) (%)
Nonrevised
(n  41) (%)
In situ 13 (48) 23 (56)
Single piece 7 (26) 10 (24)
Splice 7(26) 8 (20)
Outflow level
Below-knee popliteal 5 (18) 12 (29)
Tibial 21 (78) 25 (61)
Pedal 1 (4) 4 (10)after an abnormal duplex scan. In this group, 8 bypasses
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unchanged velocity elevations, and 35 had regression of the
PSV to 150 cm/s.
The greatest recorded PSV and Vr for the revised
bypasses were statistically significantly greater than for the
nonrevised bypasses (Table III). The greatest PSVs and Vrs
were 396  77 cm/s and 4.6  2.0 for the revised group,
and 265  77 cm/s and 3.3  1.2 for the nonrevised
group.
In the group that underwent surveillance, the first
elevated PSVs and Vrs were similar among bypasses that
had velocity progression and needed revision, had un-
changed velocities, and had velocity regression (Table IV).
The PSVs and Vrs were 278  50 cm/s and 3.3  1.3 for
the progression group, 272  61 cm/s and 3.4  1.3 for
the unchanged group, and 261  82 cm/s and 3.2  1.2
for the regression group.
For bypasses that had velocity progression during sur-
veillance, the mean time from bypass to duplex study
indicating revision was 230  177 days. For bypasses that
had velocity regression, the mean time to a PSV 150
cm/s was 203  161 days.
The volume flow data showed a statistically significant
reduction in flow in bypasses that had a velocity regression.
This volume flow change over time was absent in bypasses
that had velocity progression and needed subsequent revi-
sion. In bypasses with velocity regression, the volume flows
in a proximal bypass segment dropped from 247  130
mL/min to 151  135 mL/min (P  .05) and in a distal
bypass segment from 180  102 mL/min to 103  54
mL/min (P  .05).
This finding was absent in bypasses that underwent
revision for a stenosis that had progressed frommoderate to
high grade. In this group, proximal volume flows at the first
Table III. First duplex scan with increased velocity,
revised and surveillance
N PSV Vr Interval*
Revised 19 396  77 4.6  2.0 31  48
Surveillance 39 265  77† 3.3  1.2† 61  78
Total 68 300  96 3.6  1.5 53  58
PSV, Peak systolic velocity; Vr, velocity ratio.
*Days from bypass to first duplex scan with velocity 150.
†Unpaired t test, P  .05.
Table IV. Initial peak systolic velocity and velocity ratio
for the surveillance group
N PSV Vr
Progress to revision 8 278  50 3.3  1.3
Stable 6 272  61 3.4  1.3
Velocity normalizes 35 261  82 3.2  1.2
Total 49 265  77 3.3  1.2
PSV, Peak systolic velocity; Vr, velocity ratio.duplex with a velocity abnormality were 201  122 mL/min and 231  164 mL/min at the last duplex before
revision (P  NS). The distal volume flows at the first
duplex with a velocity abnormality were 131 40 and 149
 143 mL/min at the last duplex prior to revision (P 
NS). The differences noted between proximal and distal
volume flow measurements were due to the present of
iatrogenic arteriovenous fistulae.
The B-mode image revealed valve leaflets or small wall
defects in 28 grafts. Image defects were noted in 4 (67%) of
6 of the bypasses with a persistent stenosis, in 14 (52%) of
the 27 bypasses that underwent surgical repair, and in 10
(29%) of the 35 bypasses where stenosis regression ap-
peared to occur as the velocities normalized.
DISCUSSION
Moderate PSV elevations found during lower extremity
vein bypass surveillance have an unpredictable clinical
course. We define moderate velocity increases as a focal
PSV150 cm/s and300 cm/s. In general, a bypass with
a PSV300 cm/s undergoes arteriography, whereas those
with a PSV 300 cm/s and 150 cm/s, which we define
as a moderate velocity abnormality, undergo duplex sur-
veillance every 2 months.
The ultimate decision regarding arteriography versus
serial duplex is patient specific, however. Sixteen percent of
our patients with intermediate velocity abnormalities had
PSV progression, underwent arteriography, and were re-
vised, whereas 72% had velocity regression to a PSV 150
cm/s.
The unpredictable nature of these focal abnormalities
has been documented by Mills et al.4 In this study, 45% of
bypasses with an abnormal duplex scan had velocity pro-
gression and 32% had lesion regression. Our data show a
much greater percentage of moderate velocity abnormali-
ties undergoing regression, although this apparent discrep-
ancy may be because of a difference in the definition of our
surveillance groups. We performed arteriography and re-
vised bypasses with PSV  300 cm/s and did not surveil
this group. However, our overall bypass revision rate when
an abnormality was discovered was similar to that found by
Mills et al, with 40% in our study being revised and 45% in
the Mills study being revised.
In another recent study, Mills et al6 retrospectively
analyzed 156 vein grafts and categorized the stenotic by-
passes into two groups. The first stenosis group demon-
strated what they termed an “intermediate” stenosis (200
cm/s  PSV 300 cm/s and 2 Vr 4). The second
group had a “critical” stenosis (PSV 300 cm/s and Vr
4). They observed resolution or stabilization of the ste-
nosis in 10 (30%) of 32 grafts with an intermediate stenosis.
An additional 20 (62%) of 32 grafts characterized with an
intermediate stenosis progressed and were revised. These
authors do not discuss a reason for the stenosis regression;
however, they do advocate serial surveillance of intermedi-
ate stenoses.
An earlier report by Idu et al7 also categorized bypass
graft stenosis as intermediate or high risk based on the
velocity ratio. They supported angiographic follow-up of
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was recommended for bypasses with a Vr 4.0. Theses
authors believed the Vr to have the best correlation with the
angiographic degree of stenosis. It would appear their
intermediate group is similar to those bypasses we studied
in our regression group. However, in our experience an-
giography was selectively performed and bypass revision
could be safely performed on the basis of duplex ultrasound
results.
Most velocity abnormalities are discovered during early
surveillance, often at the first duplex study. Once identified,
the clinical course of the abnormality is usually evident by
the sixth or seventh postoperative month. Among our
patients, 25 of the 27 that ultimately underwent revision
had a focal velocity abnormality identified at the first duplex
scan. Among bypasses with stenosis progression, the aver-
age time to progression was 230 days from the date of
bypass but was highly variable, with a standard deviation of
177 days. Velocity regression occurred over a similar inter-
val (mean, 203 days) and was highly variable, with a stan-
dard deviation of 161 days. This finding is similar to that of
the Mills group,6 where all lesions that resolved did so by
postoperative month 12.
De novo velocity abnormalities after a prior normal
duplex scan are uncommon during the first year of fol-
low-up but when discovered, usually lead to revision. Only
two of our revised bypasses had an abnormal duplex result
after at least one prior normal study. In both cases, the
lesion had a PSV300 cm/s when identified, and arteriog-
raphy and revision were done without interval surveillance.
This finding is consistent with the Mills group,6 where two
of 22 revised bypasses had a de novo stenosis after prior
normal studies.
Smoking has been shown to increase the thickness of
the subendothelial basement membranes in vein grafts and
to be a risk factor for graft stenosis and vein graft throm-
bosis.8-10 Among our bypasses with abnormal duplex stud-
ies, smokers represented 34% of the nonrevised group and
11% of the revised group. These numbers do not substan-
tiate smoking as a significant risk factor associated with
bypass stenosis.
Valve related lesions might be responsible for some
moderate velocity increases found during infrainguinal vein
bypass surveillance. In a study by Vesti et al,11 valves in both
reversed and in situ saphenous vein grafts were followed by
serial duplex studies and 20 valves were identified as the
cause of a moderate- or high-grade velocity increase. Only
five of the 20 identified valves needed subsequent revision,
however. In our study, valve remnants were only identified
in 10 of the 35 bypasses that underwent regression. Valve
leaflets or remnants typically can be easily identified by
using multiple ultrasound views of the graft, and we believe
that few if any leaflets escaped identification in our study.
Other lesions apparent on the ultrasound image may
also be responsible for focal flow abnormalities that regress,
including platelet aggregates, intimal hyperplasia, or vein
injuries during preparation for bypass. No B-mode imagestenoses appeared to change over time among the bypasses
in this study.
Another mechanism for regression of a focal velocity
abnormality may be reduced volume flow as an initial phase
of hyperemic flow subsides. Doppler waveform analysis can
demonstrate hyperemic flow in some patients in which
there is continued forward flow in diastole. Diastolic flow
eventually reverses direction on follow-up examinations as
the peripheral vascular resistance in the distal vascular bed
increases and a triphasic flow pattern is regained.12 As
volume flow decreases, velocity will also decrease. We
found a statistically significant reduction in volume flow at
both the proximal and distal segments of the bypasses with
velocity regression.
Interestingly, we found no reduction in volume flow in
bypasses with moderate lesions that progressed to high
grade and were revised. We have previously shown that
reduced reactive hyperemic flow may be an indicator of
bypass stenosis.13 In this previous study, reactive hyperemia
was induced after 3 minutes of tourniquet occlusion. Per-
haps failing bypasses are already in a state of hyperemic flow
and further hyperemic stimulation fails to augment flow as
significantly as is seen with a hemodynamically successful
bypass.
The postoperative hyperemia present in bypass grafts
persists for days or weeks. In our experience, a hemody-
namically successful bypass typically has a reduction in
volume flow that plateaus during the first year of follow-up.
Absence of this pattern of reduced flow over time may
indicate a high-grade stenosis.
This study supports close surveillance of grafts with
moderately elevated velocities. Our general velocity criteria
for graft revision are a PSV 300 cm/s and a Vr 3.5.
Velocity elevations below this threshold undergo surveil-
lance at 3-month intervals. Bypass revision was necessary in
44% of the identified patients to prevent bypass thrombosis.
Of the remaining bypasses followed with moderate velocity
increases, no bypass was lost to thrombosis. Furthermore,
35 (83%) of the 42 grafts followed with moderate velocity
increases underwent resolution of flow disturbance, as
demonstrated by the normalization of the bypass velocities.
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